Hanson & Doremus Investment Management Has $1.90 Million Stake in Intuitive Surgical, Inc. $ISRG

Hanson & Doremus Investment Management lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 46.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,237 shares of the medical equipment provider’s stock after purchasing an additional 1,335 shares during the period. Hanson & Doremus Investment Management’s holdings in Intuitive Surgical were worth $1,895,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares during the period. State Street Corp grew its stake in shares of Intuitive Surgical by 1.2% in the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after acquiring an additional 182,871 shares in the last quarter. Geode Capital Management LLC increased its position in Intuitive Surgical by 1.4% during the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after acquiring an additional 109,904 shares during the period. Norges Bank acquired a new stake in Intuitive Surgical in the 2nd quarter worth about $2,569,260,000. Finally, Invesco Ltd. boosted its holdings in Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after purchasing an additional 201,159 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ISRG. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Rothschild & Co Redburn raised their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Jefferies Financial Group upped their target price on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada increased their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, Daiwa Capital Markets boosted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $611.08.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. This trade represents a 95.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $577.34 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The business’s fifty day moving average is $547.18 and its 200-day moving average is $505.91. The firm has a market cap of $206.96 billion, a price-to-earnings ratio of 76.37, a PEG ratio of 5.33 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the company earned $1.84 EPS. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.